Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A $100 Million Trial Launched Today to Test Whether GLP-1 Drugs Plus Lifestyle Changes Can Prevent Dementia The Alzheimer's Association today launched a $100 million global clinical trial designed to answer one of the most consequential questions in aging medicine: can combining a GLP-1 receptor agonist drug with a proven lifestyle intervention actually prevent dementia
The incidence of T2DM in the younger group surged by 120%, highlighting a troubling trend in youth diabetes rates
Glutathione works quietly in the background
Nausea typically diminishes significantly after the first month, and most digestive adjustments stabilize by week four to six
doi: 10.1128/MCB.05603-11 77 PrasunP
US$ 24.22
US$ 21.25
US$ 29.41
